Encompass Health (NYSE:EHC) Given New $108.00 Price Target at Barclays

Encompass Health (NYSE:EHC) had its price objective raised by Barclays from $101.00 to $108.00 in a research note released on Thursday, Benzinga reports. Barclays currently has an overweight rating on the stock.

Other analysts also recently issued reports about the company. Royal Bank of Canada reissued an outperform rating and issued a $83.00 target price on shares of Encompass Health in a research report on Friday, February 9th. Truist Financial boosted their price objective on Encompass Health from $82.00 to $86.00 and gave the company a buy rating in a research note on Friday, February 9th. Mizuho increased their target price on shares of Encompass Health from $93.00 to $95.00 and gave the stock a buy rating in a research report on Thursday. Stephens reissued an overweight rating and issued a $85.00 price target on shares of Encompass Health in a research report on Tuesday, January 16th. Finally, William Blair restated an outperform rating on shares of Encompass Health in a research note on Wednesday, February 7th. Eight investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of Buy and a consensus target price of $88.13.

Encompass Health Trading Down 0.3 %

Shares of Encompass Health stock opened at $82.47 on Thursday. The firm has a market cap of $8.26 billion, a PE ratio of 22.29, a P/E/G ratio of 1.50 and a beta of 0.94. Encompass Health has a 1 year low of $57.55 and a 1 year high of $85.84. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.37 and a quick ratio of 1.28. The stock has a fifty day moving average price of $78.25 and a 200-day moving average price of $70.96.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.93 by $0.19. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The business had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter last year, the company posted $0.88 earnings per share. The firm’s quarterly revenue was up 13.4% compared to the same quarter last year. Equities research analysts anticipate that Encompass Health will post 4.1 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.73%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health’s dividend payout ratio is presently 16.22%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of EHC. TD Asset Management Inc raised its position in shares of Encompass Health by 239.6% in the fourth quarter. TD Asset Management Inc now owns 1,969,186 shares of the company’s stock worth $131,384,000 after buying an additional 1,389,275 shares in the last quarter. 8 Knots Management LLC purchased a new stake in shares of Encompass Health in the 4th quarter valued at about $75,424,000. Norges Bank bought a new stake in shares of Encompass Health during the 4th quarter valued at about $69,178,000. Invesco Ltd. grew its holdings in shares of Encompass Health by 22.3% during the third quarter. Invesco Ltd. now owns 3,974,306 shares of the company’s stock worth $266,914,000 after purchasing an additional 724,544 shares in the last quarter. Finally, Epoch Investment Partners Inc. increased its position in shares of Encompass Health by 102.9% in the fourth quarter. Epoch Investment Partners Inc. now owns 1,399,341 shares of the company’s stock worth $93,364,000 after purchasing an additional 709,593 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.